MHRA set to reclassify glucosamine supplements
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
High-strength glucosamine food supplements sold in the UK will now be classified as medicines and require a marketing authorisation after the country’s Medicines and Healthcare products Regulatory Agency (MHRA) introduced tighter regulations for such products.
You may also be interested in...
France Warns Diabetics And Others Against Using Joint Health Supplements
Diabetics, pregnant women, children, and those with certain food allergies in France should stop taking joint health supplements containing glucosamine and/or chondroitin sulfate due to a risk of adverse events, says national food regulator ANSES. Local supplements industry association Synadiet has insisted the products are safe and cases of adverse reactions rare.
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.